These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38402145)

  • 21. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.
    Gómez-Duarte OG; Lucas B; Yan ZX; Panthel K; Haas R; Meyer TF
    Vaccine; 1998 Mar; 16(5):460-71. PubMed ID: 9491500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2017 Feb; 111():33-43. PubMed ID: 27865932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
    Zhong Y; Chen J; Liu Y; Zhang Y; Tang C; Wang X; Wang P; Chen W; Wei B; Liu M
    Microb Pathog; 2020 Aug; 145():104229. PubMed ID: 32353579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
    Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
    Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development.
    Zhang R; Duan G; Shi Q; Chen S; Fan Q; Sun N; Xi Y
    Biotechnol Lett; 2016 Nov; 38(11):1911-1916. PubMed ID: 27406731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
    Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
    J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B.
    Gu Q; Song D; Zhu M
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):197-203. PubMed ID: 19453750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W; Wu W; Xu X
    Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
    Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Administration of a
    Zhang X; Sang S; Guan Q; Tao H; Wang Y; Liu C
    Front Immunol; 2022; 13():894206. PubMed ID: 35769459
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.
    Hongying F; Xianbo W; Fang Y; Yang B; Beiguo L
    Clin Vaccine Immunol; 2014 Feb; 21(2):126-32. PubMed ID: 24285819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants-A review.
    Yunle K; Tong W; Jiyang L; Guojun W
    Helicobacter; 2024; 29(1):e13034. PubMed ID: 37971157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
    Zhou Z; Dong H; Huang Y; Yao S; Liang B; Xie Y; Long Y; Mai J; Gong S
    J Med Microbiol; 2017 Jan; 66(1):83-89. PubMed ID: 27930268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting Immune Efficacy of the Oral Helicobacter pylori Vaccine by HP55/PBCA Nanoparticles against the Gastrointestinal Environment.
    Liu H; Liu W; Tan Z; Zeng Z; Yang H; Luo S; Wang L; Xi T; Xing Y
    Mol Pharm; 2018 Aug; 15(8):3177-3186. PubMed ID: 30011213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
    Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
    Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
    Guo L; Li X; Tang F; He Y; Xing Y; Deng X; Xi T
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1937-45. PubMed ID: 22134639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.